Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240376R1
John Heintzman, Tahlia Hodes, Steffani R Bailey, Christopher G Slatore, Wyatt P Bensken, Jennifer A Lucas, Matthew P Banegas, Gretchen Mertes, Miguel Marino
Introduction: United States Preventive Service Task Force guidelines recommend annual low-dose computed tomography for lung cancer screening (LCS) for people with significant history of cigarette use. While the national prevalence of lung cancer screening remains low, with known racial and ethnic disparities, studies have yet to examine LCS screening disparities by nativity among Latino patients.
Methods: We evaluated the documentation and prevalence of LCS orders in the electronic health record in Latino patients, by place of birth, in a multistate network of community health centers, over a 10-year study period (2013 to 2022), adjusting for patient and clinical demographic factors.
Results: Among patients who reported current or former cigarette use (n = 126,528), the prevalence of a LCS order was 7.3%. Among 62,483 patients with a documented 30+ year pack-history, US-born Latinos had equal odds as non-Latino Whites to have LCS ordered (OR = 0.71, 95% CI = 0.42-1.21), while odds were lower for both foreign-born Latinos (OR = 0.47, 95% CI = 0.29 to 0.75) and Latinos without a place of birth recorded (OR = 0.63, 95% CI = 0.54-0.73).
Conclusion: The prevalence of LCS was low overall in a large sample of Latino and non-Hispanic White patients with cigarette smoking history. Foreign-born Latino and Latino patients without a country of birth noted in the record had significantly lower odds of having LCS ordered; this should be considered in clinical screening workflows. Nativity and pack-year history were not documented in most patients. More complete documentation of nativity and pack-year history is necessary to fully assess LCS need and equity in Latino patients of heterogeneous nativity.
简介:美国预防服务工作组指南建议每年对有明显吸烟史的人进行低剂量ct肺癌筛查(LCS)。虽然全国肺癌筛查的流行率仍然很低,并且存在已知的种族和民族差异,但研究尚未检查拉丁裔患者中出生的LCS筛查差异。方法:在10年的研究期间(2013年至2022年),我们在多州社区卫生中心网络中评估拉丁裔患者电子健康记录中LCS订单的记录和流行程度,并根据患者和临床人口统计学因素进行调整。结果:在报告当前或曾经吸烟的患者中(n = 126528), LCS订单的患病率为7.3%。在62,483例有30年以上病史的患者中,美国出生的拉丁裔与非拉丁裔白人有相同的几率进行LCS (OR = 0.71, 95% CI = 0.42-1.21),而外国出生的拉丁裔(OR = 0.47, 95% CI = 0.29 - 0.75)和没有出生记录的拉丁裔(OR = 0.63, 95% CI = 0.54-0.73)的几率较低。结论:在大量有吸烟史的拉美裔和非拉美裔白人患者中,LCS的总体患病率较低。外国出生的拉丁裔和没有出生国家记录的拉丁裔患者订购LCS的几率显着降低;在临床筛查工作流程中应考虑到这一点。大多数患者无出生年月史。更完整的出生和包年历史的文件是必要的,以充分评估LCS的需求和公平的拉丁裔患者的异质出生。
{"title":"Lung Cancer Screening by Nativity Among Latino Community Health Center Patients.","authors":"John Heintzman, Tahlia Hodes, Steffani R Bailey, Christopher G Slatore, Wyatt P Bensken, Jennifer A Lucas, Matthew P Banegas, Gretchen Mertes, Miguel Marino","doi":"10.3122/jabfm.2024.240376R1","DOIUrl":"10.3122/jabfm.2024.240376R1","url":null,"abstract":"<p><strong>Introduction: </strong>United States Preventive Service Task Force guidelines recommend annual low-dose computed tomography for lung cancer screening (LCS) for people with significant history of cigarette use. While the national prevalence of lung cancer screening remains low, with known racial and ethnic disparities, studies have yet to examine LCS screening disparities by nativity among Latino patients.</p><p><strong>Methods: </strong>We evaluated the documentation and prevalence of LCS orders in the electronic health record in Latino patients, by place of birth, in a multistate network of community health centers, over a 10-year study period (2013 to 2022), adjusting for patient and clinical demographic factors.</p><p><strong>Results: </strong>Among patients who reported current or former cigarette use (n = 126,528), the prevalence of a LCS order was 7.3%. Among 62,483 patients with a documented 30+ year pack-history, US-born Latinos had equal odds as non-Latino Whites to have LCS ordered (OR = 0.71, 95% CI = 0.42-1.21), while odds were lower for both foreign-born Latinos (OR = 0.47, 95% CI = 0.29 to 0.75) and Latinos without a place of birth recorded (OR = 0.63, 95% CI = 0.54-0.73).</p><p><strong>Conclusion: </strong>The prevalence of LCS was low overall in a large sample of Latino and non-Hispanic White patients with cigarette smoking history. Foreign-born Latino and Latino patients without a country of birth noted in the record had significantly lower odds of having LCS ordered; this should be considered in clinical screening workflows. Nativity and pack-year history were not documented in most patients. More complete documentation of nativity and pack-year history is necessary to fully assess LCS need and equity in Latino patients of heterogeneous nativity.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"451-463"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240388R2
Tamar Wyte-Lake, Deborah J Cohen, Shannon Williams, Steffani R Bailey
Background: Hybrid models of care (ie, telehealth and in-person care delivery options) have been incorporated into primary care clinics to increase patient access to care. We examine the effects of these approaches on the work experiences and wellness of primary care clinical team members providing team-based care to patients.
Methods: In this qualitative study, we conducted semistructured interviews with clinical team members (primary care clinicians, behavioral health consultants, registered nurse) at 2 primary care practices at 2 time points (late 2021-mid 2022 (n = 14); midlate 2023 (n = 11)). We used an inductive approach to analyze data.
Key results: Benefits of hybrid models of care included increased patient access and personal flexibility; however, it was noted that the fragmented in-clinic schedules that emerged from the hybrid model resulted in reduced in-clinic interactions. This led to less information sharing among team members and a degradation of informal support networks that could adversely impact patient care. To mitigate these challenges, many preferred that most of their clinical shifts occurred in-person, in the clinic, with 1 to 2 sessions per week for in-home (telework) shifts.
Conclusions: In team-based primary care clinics, hybrid care models can impact interactions among clinical team members and shape the day-to-day environment in which clinical teams work. To optimize hybrid care approaches in the primary care setting, organization leaders must consider the impact of hybrid care models on clinic and team culture, and the well-being of clinical team members.
{"title":"Balancing Access, Well-Being, and Collaboration When Considering Hybrid Care Delivery Models in Primary Care Practices with Team-Based Care.","authors":"Tamar Wyte-Lake, Deborah J Cohen, Shannon Williams, Steffani R Bailey","doi":"10.3122/jabfm.2024.240388R2","DOIUrl":"10.3122/jabfm.2024.240388R2","url":null,"abstract":"<p><strong>Background: </strong>Hybrid models of care (ie, telehealth and in-person care delivery options) have been incorporated into primary care clinics to increase patient access to care. We examine the effects of these approaches on the work experiences and wellness of primary care clinical team members providing team-based care to patients.</p><p><strong>Methods: </strong>In this qualitative study, we conducted semistructured interviews with clinical team members (primary care clinicians, behavioral health consultants, registered nurse) at 2 primary care practices at 2 time points (late 2021-mid 2022 (n = 14); midlate 2023 (n = 11)). We used an inductive approach to analyze data.</p><p><strong>Key results: </strong>Benefits of hybrid models of care included increased patient access and personal flexibility; however, it was noted that the fragmented in-clinic schedules that emerged from the hybrid model resulted in reduced in-clinic interactions. This led to less information sharing among team members and a degradation of informal support networks that could adversely impact patient care. To mitigate these challenges, many preferred that most of their clinical shifts occurred in-person, in the clinic, with 1 to 2 sessions per week for in-home (telework) shifts.</p><p><strong>Conclusions: </strong>In team-based primary care clinics, hybrid care models can impact interactions among clinical team members and shape the day-to-day environment in which clinical teams work. To optimize hybrid care approaches in the primary care setting, organization leaders must consider the impact of hybrid care models on clinic and team culture, and the well-being of clinical team members.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"475-489"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2025.250014R0
Kathryn K Garner, Chris Colvin, Brock Cardon
Initiation of pitavastatin in adults aged 40 to 75 living with HIV treated with highly active antiretroviral therapy (HAART) with low-to-moderate 10-year atherosclerotic cardiovascular disease (ASCVD) risk decreases the incidence of major cardiovascular events (MACE).
{"title":"Pitavastatin Reduces Major Atherosclerotic Cardiovascular Events in Adults with HIV.","authors":"Kathryn K Garner, Chris Colvin, Brock Cardon","doi":"10.3122/jabfm.2025.250014R0","DOIUrl":"10.3122/jabfm.2025.250014R0","url":null,"abstract":"<p><p>Initiation of pitavastatin in adults aged 40 to 75 living with HIV treated with highly active antiretroviral therapy (HAART) with low-to-moderate 10-year atherosclerotic cardiovascular disease (ASCVD) risk decreases the incidence of major cardiovascular events (MACE).</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"586-588"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2025.250001R0
Benjamin Feijóo, Roxanne Radi, Corey Lyon
In patients younger than 21 years of age with a provoked deep venous thrombosis (DVT), anticoagulation for 6 weeks is noninferior to anticoagulation for 3 months.1.
对于年龄小于21岁的深静脉血栓(DVT)患者,6周抗凝治疗优于3个月抗凝治疗。
{"title":"Reducing Anticoagulation Duration for Children After a Provoked Deep Venous Thrombosis.","authors":"Benjamin Feijóo, Roxanne Radi, Corey Lyon","doi":"10.3122/jabfm.2025.250001R0","DOIUrl":"10.3122/jabfm.2025.250001R0","url":null,"abstract":"<p><p>In patients younger than 21 years of age with a provoked deep venous thrombosis (DVT), anticoagulation for 6 weeks is noninferior to anticoagulation for 3 months.<sup>1</sup>.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"589-591"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240220R3
Mechelle Sanders, Anna Russell, Kaela Mali, Jenny Ganay Vasquez, Sean Chambers, Holly Ann Russell
Purpose: The few studies about primary care based controlled substance safety committees (CSSC) to date have been primarily quantitative, focused on patient outcomes and lacked contextual data around their implementation. The purpose of this study is to qualitatively identify barriers and facilitators to the use of CDCs guidelines around opioid prescribing and the implementation of controlled substance safety committee in a primary care practice.
Methods: Ten semistructured interviews were conducted with primary care clinicians in an academic medical practice. Potential barriers and facilitators to the uptake and use of the CDC opioid guidelines and the practice's CSSC were coded and analyzed against the Capability, Opportunity, and Motivation framework for Behavior change framework (COM-B).
Results: Six key themes were identified around uptake of the CDC guidelines. In general, the CSSC addressed some of the capability barriers around the guidelines but had limited impact on increasing motivation to follow the guidelines. We found the same recommendation in the guidelines could have differing impact on prescribing behavior.
Conclusions: Simply promoting guidelines may be insufficient, especially for those viewing them as rules rather than recommendations. Our findings underscore the fact that guidelines are merely a starting point, not an endpoint of implementation.
{"title":"Understanding the Barriers and Facilitators of Implementing a Controlled Substance Safety Committee in a Primary Care Practice.","authors":"Mechelle Sanders, Anna Russell, Kaela Mali, Jenny Ganay Vasquez, Sean Chambers, Holly Ann Russell","doi":"10.3122/jabfm.2024.240220R3","DOIUrl":"10.3122/jabfm.2024.240220R3","url":null,"abstract":"<p><strong>Purpose: </strong>The few studies about primary care based controlled substance safety committees (CSSC) to date have been primarily quantitative, focused on patient outcomes and lacked contextual data around their implementation. The purpose of this study is to qualitatively identify barriers and facilitators to the use of CDCs guidelines around opioid prescribing and the implementation of controlled substance safety committee in a primary care practice.</p><p><strong>Methods: </strong>Ten semistructured interviews were conducted with primary care clinicians in an academic medical practice. Potential barriers and facilitators to the uptake and use of the CDC opioid guidelines and the practice's CSSC were coded and analyzed against the Capability, Opportunity, and Motivation framework for Behavior change framework (COM-B).</p><p><strong>Results: </strong>Six key themes were identified around uptake of the CDC guidelines. In general, the CSSC addressed some of the capability barriers around the guidelines but had limited impact on increasing motivation to follow the guidelines. We found the same recommendation in the guidelines could have differing impact on prescribing behavior.</p><p><strong>Conclusions: </strong>Simply promoting guidelines may be insufficient, especially for those viewing them as rules rather than recommendations. Our findings underscore the fact that guidelines are merely a starting point, not an endpoint of implementation.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"577-585"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240302R2
David C Mallinson
Introduction: This study evaluates participation in Wisconsin Medicaid's Prenatal Care Coordination (PNCC) program and its association with children's well-child visit (WCV) receipt.
Study design: Data came from linked Wisconsin birth records (2011 to 2015) and Medicaid claims and enrollment data (2010 to 2019). The sample comprised 113,347 children with Medicaid-paid births and continuous Medicaid enrollment ranging from 12 to 48 months post-birth. A sibling subsample comprised of 35,373 children. PNCC receipt in pregnancy was measured dichotomously (none; any) and categorically (none; assessment/care plan only; service uptake). Any WCV receipt and recommended WCV receipt (which varied by age) were measured during each year from age 0 up to 4 years old. Conventional logistic regressions and sibling fixed effects (FE) regressions estimated associations between PNCC receipt and WCV receipt.
Results: Demographic-adjusted sibling FE regressions-which best control for unobserved confounding-indicated that any PNCC was positively associated with children receiving any WCVs at age 0 to <1 year-old (OR 1.48; 95% CI 1.05-2.08) and at age 1 to <2 years old (OR 1.24; 95% CI 1.03-1.50). In addition, adjusted sibling FE regressions found that PNCC service uptake was associated with children receiving the recommended number of WCVs at age 0 to <1 year-old (OR 1.35; 95% CI 1.18-1.55).
Conclusions: PNCC may improve children's WCV attendance in the first 2 years of life. Findings underscore the potential for obstetric care coordination programs to enhance the continuity of preventive care for participating families.
{"title":"Prenatal Care Coordination and Well-Child Visit Receipt in Early Childhood.","authors":"David C Mallinson","doi":"10.3122/jabfm.2024.240302R2","DOIUrl":"10.3122/jabfm.2024.240302R2","url":null,"abstract":"<p><strong>Introduction: </strong>This study evaluates participation in Wisconsin Medicaid's Prenatal Care Coordination (PNCC) program and its association with children's well-child visit (WCV) receipt.</p><p><strong>Study design: </strong>Data came from linked Wisconsin birth records (2011 to 2015) and Medicaid claims and enrollment data (2010 to 2019). The sample comprised 113,347 children with Medicaid-paid births and continuous Medicaid enrollment ranging from 12 to 48 months post-birth. A sibling subsample comprised of 35,373 children. PNCC receipt in pregnancy was measured dichotomously (none; any) and categorically (none; assessment/care plan only; service uptake). Any WCV receipt and recommended WCV receipt (which varied by age) were measured during each year from age 0 up to 4 years old. Conventional logistic regressions and sibling fixed effects (FE) regressions estimated associations between PNCC receipt and WCV receipt.</p><p><strong>Results: </strong>Demographic-adjusted sibling FE regressions-which best control for unobserved confounding-indicated that any PNCC was positively associated with children receiving any WCVs at age 0 to <1 year-old (OR 1.48; 95% CI 1.05-2.08) and at age 1 to <2 years old (OR 1.24; 95% CI 1.03-1.50). In addition, adjusted sibling FE regressions found that PNCC service uptake was associated with children receiving the recommended number of WCVs at age 0 to <1 year-old (OR 1.35; 95% CI 1.18-1.55).</p><p><strong>Conclusions: </strong>PNCC may improve children's WCV attendance in the first 2 years of life. Findings underscore the potential for obstetric care coordination programs to enhance the continuity of preventive care for participating families.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"513-538"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240358R1
Sebastian T Tong, Melinda M Davis, Allison M Cole
Even though 20% of Americans live in rural communities, few research studies intentionally include or engage rural communities. The National Institutes of Health recently launched the CARE for Health™ Initiative that is initially focusing on engaging rural communities and primary care practices in research. In this commentary, we describe activities designed to improve rural clinical and community engagement in research led by two practice-based research networks (the Oregon Rural Practice Research Network and the WWAMI [Washington, Wyoming, Alaska, Montana and Idaho] region Practice and Research Network) funded through this initiative.
尽管20%的美国人生活在农村社区,但很少有研究有意地包括或涉及农村社区。美国国立卫生研究院(National Institutes of Health)最近启动了CARE for Health™倡议,最初的重点是让农村社区和初级保健实践参与研究。在这篇评论中,我们描述了旨在改善农村临床和社区参与研究的活动,这些研究由两个基于实践的研究网络(俄勒冈农村实践研究网络和WWAMI[华盛顿,怀俄明,阿拉斯加,蒙大拿州和爱达荷州]地区实践和研究网络)领导。
{"title":"Conducting Research That Matters to Rural Practice and Communities.","authors":"Sebastian T Tong, Melinda M Davis, Allison M Cole","doi":"10.3122/jabfm.2024.240358R1","DOIUrl":"10.3122/jabfm.2024.240358R1","url":null,"abstract":"<p><p>Even though 20% of Americans live in rural communities, few research studies intentionally include or engage rural communities. The National Institutes of Health recently launched the CARE for Health™ Initiative that is initially focusing on engaging rural communities and primary care practices in research. In this commentary, we describe activities designed to improve rural clinical and community engagement in research led by two practice-based research networks (the Oregon Rural Practice Research Network and the WWAMI [Washington, Wyoming, Alaska, Montana and Idaho] region Practice and Research Network) funded through this initiative.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"603-606"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240394R1
Elisabeth Callen, Kathryn Istas, Natabhona Mabachi, Tarin Clay
Introduction: Physician workforce shortages are expected to reach 48,000 primary care physicians by 2034 with burnout, discrimination (gender, race, and others), and harassment as contributors. Physicians experience discrimination and harassment on a daily basis and continue to work with patients who routinely discriminate against them, which can be directly related to burnout.
Methods: The American Academy of Family Physicians (AAFP) created the Leading Physician Well-Being Certificate Program to combat these issues. Surveys were sent to cohorts at multiple time points - beginning, middle, and end. Multiple evaluation instruments were included in these surveys, but for this analysis, we focused on the Everyday Discrimination Scale (EDS). For Cohort 1 (n = 88, 2021), they received the EDS midway through their cohort. For Cohort 2 (n = 62, 2022), they received the EDS at each time point, but received a Privilege Assessment midway through their cohort due to their answers on the EDS.
Results: Cohort 1 consistently rated the questions with higher levels of discrimination than Cohort 2 scholars. In general, Asian women from Cohort 1 experienced the most discrimination of all the groups (7 statements). For the Privilege Assessment, Asian and other women of color were more likely to indicate less privilege than other groups.
Discussion: Physicians taking the AAFP Leading Physician Well-Being Certificate Program reported have experienced discrimination and harassment. Certain physician groups experience higher levels of discrimination and harassment, and concurrent lower levels of privilege. While unfortunate, discrimination and harassment will continue to play a large role in physicians' lives.
{"title":"Physician Experience of Discrimination in a Leadership and Well-Being Program.","authors":"Elisabeth Callen, Kathryn Istas, Natabhona Mabachi, Tarin Clay","doi":"10.3122/jabfm.2024.240394R1","DOIUrl":"10.3122/jabfm.2024.240394R1","url":null,"abstract":"<p><strong>Introduction: </strong>Physician workforce shortages are expected to reach 48,000 primary care physicians by 2034 with burnout, discrimination (gender, race, and others), and harassment as contributors. Physicians experience discrimination and harassment on a daily basis and continue to work with patients who routinely discriminate against them, which can be directly related to burnout.</p><p><strong>Methods: </strong>The American Academy of Family Physicians (AAFP) created the Leading Physician Well-Being Certificate Program to combat these issues. Surveys were sent to cohorts at multiple time points - beginning, middle, and end. Multiple evaluation instruments were included in these surveys, but for this analysis, we focused on the Everyday Discrimination Scale (EDS). For Cohort 1 (n = 88, 2021), they received the EDS midway through their cohort. For Cohort 2 (n = 62, 2022), they received the EDS at each time point, but received a Privilege Assessment midway through their cohort due to their answers on the EDS.</p><p><strong>Results: </strong>Cohort 1 consistently rated the questions with higher levels of discrimination than Cohort 2 scholars. In general, Asian women from Cohort 1 experienced the most discrimination of all the groups (7 statements). For the Privilege Assessment, Asian and other women of color were more likely to indicate less privilege than other groups.</p><p><strong>Discussion: </strong>Physicians taking the AAFP Leading Physician Well-Being Certificate Program reported have experienced discrimination and harassment. Certain physician groups experience higher levels of discrimination and harassment, and concurrent lower levels of privilege. While unfortunate, discrimination and harassment will continue to play a large role in physicians' lives.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"566-576"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240274R1
Tomás González-Vidal, Óscar Lado-Baleato, Carmen Fernández-Merino, Juan Sánchez-Castro, Manuela Alonso-Sampedro, Jessica Ares, Elías Delgado, Edelmiro Menéndez-Torre, Francisco Gude
Background: There are no studies on the clinical significance of asymptomatic hypoglycemia detected incidentally during routine testing.
Methods: Baseline fasting serum glucose was determined in 1333 individuals without diabetes (43.3% males, median age 50 years, range 18 to 91 years) to investigate the prevalence of hypoglycemia (fasting serum glucose <70 mg/dL) and the associated demographic, lifestyle, and metabolic factors. Individuals with baseline hypoglycemia were followed (median follow-up, 8.7 years) and assessed for hypoglycemia symptoms. Seven-day continuous glucose monitoring was performed in a subsample of 489 individuals.
Results: Baseline hypoglycemia was observed in 20 individuals (weighted prevalence, 1.58%, 95% confidence interval 0.87%-2.28%). Hypoglycemia was mild and asymptomatic in all cases (median, 67 mg/dL, range 63 to 69 mg/dL). The characteristics of those with hypoglycemia were similar to those with fasting serum glucose 70 to 80 mg/dL. Hypoglycemia was associated with female sex, younger age, and a more favorable metabolic profile (lower body mass index, glycohemoglobin and insulin resistance) than individuals with fasting serum glucose >80 mg/dL. Individuals with baseline hypoglycemia showed no distinct hypoglycemia features in continuous glucose monitoring (n = 9). During follow-up (n = 19), hypoglycemia in routine determinations, always mild, recurred in 42.1% of individuals, although the mean of successive glucose concentrations was higher than baseline in all cases. None of the individuals had symptoms that could constitute Whipple's triad (low serum glucose, symptoms of hypoglycemia, and symptomatic improvement after correction of hypoglycemia) during the follow-up period.
Conclusions: Detection of asymptomatic, mild hypoglycemia in routine blood tests is not indicative of disease and does not require further investigation.
{"title":"Evaluation of Asymptomatic Fasting Hypoglycemia in Outpatients Without Diabetes.","authors":"Tomás González-Vidal, Óscar Lado-Baleato, Carmen Fernández-Merino, Juan Sánchez-Castro, Manuela Alonso-Sampedro, Jessica Ares, Elías Delgado, Edelmiro Menéndez-Torre, Francisco Gude","doi":"10.3122/jabfm.2024.240274R1","DOIUrl":"10.3122/jabfm.2024.240274R1","url":null,"abstract":"<p><strong>Background: </strong>There are no studies on the clinical significance of asymptomatic hypoglycemia detected incidentally during routine testing.</p><p><strong>Methods: </strong>Baseline fasting serum glucose was determined in 1333 individuals without diabetes (43.3% males, median age 50 years, range 18 to 91 years) to investigate the prevalence of hypoglycemia (fasting serum glucose <70 mg/dL) and the associated demographic, lifestyle, and metabolic factors. Individuals with baseline hypoglycemia were followed (median follow-up, 8.7 years) and assessed for hypoglycemia symptoms. Seven-day continuous glucose monitoring was performed in a subsample of 489 individuals.</p><p><strong>Results: </strong>Baseline hypoglycemia was observed in 20 individuals (weighted prevalence, 1.58%, 95% confidence interval 0.87%-2.28%). Hypoglycemia was mild and asymptomatic in all cases (median, 67 mg/dL, range 63 to 69 mg/dL). The characteristics of those with hypoglycemia were similar to those with fasting serum glucose 70 to 80 mg/dL. Hypoglycemia was associated with female sex, younger age, and a more favorable metabolic profile (lower body mass index, glycohemoglobin and insulin resistance) than individuals with fasting serum glucose >80 mg/dL. Individuals with baseline hypoglycemia showed no distinct hypoglycemia features in continuous glucose monitoring (n = 9). During follow-up (n = 19), hypoglycemia in routine determinations, always mild, recurred in 42.1% of individuals, although the mean of successive glucose concentrations was higher than baseline in all cases. None of the individuals had symptoms that could constitute Whipple's triad (low serum glucose, symptoms of hypoglycemia, and symptomatic improvement after correction of hypoglycemia) during the follow-up period.</p><p><strong>Conclusions: </strong>Detection of asymptomatic, mild hypoglycemia in routine blood tests is not indicative of disease and does not require further investigation.</p>","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"411-422"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.3122/jabfm.2024.240404R0
Karim Hanna
{"title":"Re: Performance Evaluation of the Generative Pre-Trained Transformer (GPT-4) on the Family Medicine In Training Examination.","authors":"Karim Hanna","doi":"10.3122/jabfm.2024.240404R0","DOIUrl":"10.3122/jabfm.2024.240404R0","url":null,"abstract":"","PeriodicalId":50018,"journal":{"name":"Journal of the American Board of Family Medicine","volume":" ","pages":"607"},"PeriodicalIF":2.6,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12616791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}